The eyes have it: when skin findings prompt referral to ophthalmology.
Journal
Current opinion in pediatrics
ISSN: 1531-698X
Titre abrégé: Curr Opin Pediatr
Pays: United States
ID NLM: 9000850
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
entrez:
15
7
2022
pubmed:
16
7
2022
medline:
19
7
2022
Statut:
ppublish
Résumé
Co-presentation of ocular and cutaneous conditions is common and prompt recognition of known associations may be imperative to sight-saving intervention. There are currently limited reviews in the pediatric literature addressing comorbid ocular and dermatologic presentations. Recent diagnostic and therapeutic advances have drastically altered the prognostic landscape for several disease states when recognition and referral are timely. The aim of this report is to examine important oculocutaneous disease associations with emphasis on management of ocular complications and appropriate referral practices to ophthalmology specialists. Oculocutaneous associations can be broadly classified into four etiologic categories: infectious, inflammatory, genetic, and medication/nutrition induced pathology. Several conditions in all four categories have had recent advances in their etiologic understanding, diagnostic evaluation, and therapeutic approach. Thematically, these advances highlight increasing disease prevalence of certain conditions, previously unrecognized pediatric relevance of others, updated diagnostic criteria, and newer categories of iatrogenic illness induced by advances in medical therapy. This review is designed to provide the pediatric practitioner a vignette-based high-level overview of both common and sight threatening associations that should prompt consideration for ophthalmology consultation. Conditions were selected based on relevance, relative urgency, and recent advances in their etiologic/therapeutic understanding.
Identifiants
pubmed: 35836396
doi: 10.1097/MOP.0000000000001143
pii: 00008480-202208000-00014
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
381-389Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
McCormick I, James C, Welton NJ, et al. Incidence of herpes simplex virus keratitis and other ocular disease: global review and estimates. Ophthalmic Epidemiol 2021; 8:1–10.
Ahmad B, Patel BC. Herpes Simplex Keratitis. 2022 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 31424862.
Green LK, Pavan-Langston D. Herpes simplex ocular inflammatory disease. Int Ophthalmol Clin. 2006 Spring;46:27-37.
Tuli SS. Yanoff M, Duker JS. Herpes simplex keratitis. Opthalmology. 3rd ed.Philadelphia, PA: Mosby; 2008. 279–284.
Rao PK. Yanoff M, Duker JS. Herpes and other viral infections. Opthalmology. 3rd ed.Philadelphia, PA: Mosby; 2008. 789–793.
Ali OB, et al. Visual outcomes of herpes simplex keratitis in children age 6 years and younger. Presented at: American Association for Pediatric Ophthalmology and Strabismus annual meeting; April 9-11, 2021 (virtual meeting). Available from: https://www.healio.com/news/ophthalmology/20210412/early-diagnosis-of-herpes-simplex-keratitis-in-children-yields-best-outcomes . Accessed: 20 June 2022
Barker NH. Ocular herpes simplex. Clin Evid (Online) 2008; 2008:0707.
Horner ME, Abramson AK, Warren RB, et al. The spectrum of oculocutaneous disease: Part 1. Infectious, inflammatory, and genetic causes of oculocutaneous disease. J Am Acad Dermatol 2014; 70:795e1–795e25.
Barfell A, et al. Syphlitic Keratitis. 2022; Philadelphia, PA: Am Acad Ophthalmology Eyewiki [Internet], Available from: https://eyewiki.aao.org/Syphilitic_Keratitis . [Accessed 20 June 2022].
Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1–187.
Bowen VB, McDonald R, Grey JA, et al. High congenital syphilis case counts among U.S. infants born in 2020. N Engl J Med 2021; 385:1144–1145.
Dobson SR (2022). Congenital syphilis: Clinical features and diagnosis. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA (Accessed on 22 March, 2022). Available from: https://www.uptodate.com/contents/congenital-syphilis-clinical-features-and-diagnosis?search=Congenital%20syphilis:%20Clinical%20features%20and%20diagnosis.%20&source=search_result&selectedTitle=1∼61&usage_type=default&display_rank=1 .
StatPearls Publishing, Koundanya VV, Tripathy K. Syphilis Ocular Manifestations. 2022 Feb 21. In: StatPearls [Internet]. 2022; Treasure Island (FL),
Day A, Abramson AK, Patel M, et al. The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease. J Am Acad Dermatol 2014; 70:821.e1–821.e19.
Boos MD, Bozarth XL, Sidbury R, et al. Forehead location and large segmental pattern of facial port-wine stains predict risk of Sturge-Weber syndrome. J Am Acad Dermatol 2020; 83:1110–1117.
Aref AA. Sturge-Weber Syndrome and Secondary Glaucoma. 2021 Nov 02. Am Acad Ophthalmology EyeWiki [Internet]. Accessed: March 2022. Available from: https://eyewiki.aao.org/Sturge-Weber_Syndrome_and_Secondary_Glaucoma#cite_note-:1-4 .
Rujimethapass N, Manuskiatti W, Wanitphakdeedecha R, Petchyim S. Ocular manifestations of facial port-wine stain, nevus of Ota, and phakomatosis pigmentovascularis in Asian patients. J Am Acad Dermatol 2021; 85:1194–1200.
Jung JL, Slegel LM, Elchenfield LF, Lueder G. Ocular Manifestations of Dermatologic Diseases. In: The Eye in Pediatric Systemic Disease - Leven AV, Enznauer RW (eds). Springer International Publishing Switzerland 2017. p. 197-239. DOI 10.1007/978-3-319-18389-3_8
Samuelov L, Kinori M, Mancini AJ, et al. Ocular Complications in PHACE Syndrome: a true association or a coincidence? J Pediatr 2019; 204:214–218.e2.
Kini A, et al. Ocular Manifestations of Phakomatoses (Neurocutaneous Syndromes). 2022 Feb 04. Am Acad Ophthalmology EyeWiki [Internet]. Accessed: March 2022. Available from: https://eyewiki.aao.org/Ocular_Manifestations_of_Phakomatoses_(Neurocutaneous_Syndromes)#cite_note-8
Legius E, Messiaen L, Wolkenstein P, et al. International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC), Huson SM, Evans DG, Plotkin SR. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 2021; 23:1506–1513.
Heymann WR. Neurofibromatosis Type 1, Juvenile Xanthogranuloma, and Leukemia: Wasting a Good Worry? 2017 May 22. In: Dermatology World Insights and Inquiries [Internet]. Am Acad Dermatology. Accessed: March 2022. Available from: https://www.aad.org/dw/dw-insights-and-inquiries/dermatopathology/neurofibromatosis-type-1-juvenile-xanthogranuloma-and-leukemia-wasting-a-good-worry
Gan TS, Juares Rizal A, Salim NL, et al. Ocular co-morbidities in patients with atopic dermatitis - a cross-sectional study from a tertiary referral hospital, Malaysia. Med J Malaysia 2022; 77:6–11.
Beck KM, Seitzman GD, Yang EJ, et al. Ocular co-morbidities of atopic dermatitis. Part I: associated ocular diseases. Am J Clin Dermatol 2019; 20:797–805.
Addis H, Jeng BH. Vernal keratoconjunctivitis. Clin Ophthalmol 2018; 12:119–123.
Sahebjada S, Al-Mahrouqi HH, Moshegov S, et al. Eye rubbing in the aetiology of keratoconus: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 2021; 259:2057–2067.
Bair B, Dodd J, Heidelberg K, Krach K. Cataracts in atopic dermatitis: a case presentation and review of the literature. Arch Dermatol 2011; 147:585–588.
Popiela MZ, Barbara R, Turnbull AMJ, et al. Dupilumab-associated ocular surface disease: presentation, management, and long-term sequelae. Eye (Lond) 2021; 35:3277–3284.
Achten RE, Van Luijk C, Van der Rijst L, et al. Identification of risk factors for dupilumab-associated ocular surface disease in patients with atopic dermatitis. Acta Derm Venereol 2022; 102:adv00666.
Al Akrash LS, Al Semari MA, Al Harithy R. Ocular manifestations of dermatological diseases part I: infectious and inflammatory disorders. Int J Dermatol 2021; 60:5–11.
Kiafar M, Faezi ST, Kasaeian A, et al. Diagnosis of Behçet's disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol 2021; 5:2.
Nair JR, Moots RJ. Behcet's disease. Clin Med (Lond) 2017; 17:71–77.
Kul Cinar O, Romano M, Guzel F, et al. Paediatric Behçet's disease: a comprehensive review with an emphasis on monogenic mimics. J Clin Med 2022; 11:1278.
McKenna D, McLaughlin D, McLoone E, et al. A case of paediatric ocular Behcet's. Rheumatol Adv Pract 2021; 5: (Suppl 1): XX.
Nguyen A, Upadhyay S, Javaid MA, et al. Behcet's disease: an in-depth review about pathogenesis, gastrointestinal manifestations, and management. Inflamm Intest Dis 2021; 6:175–185.
Child Maltreatment Report 2020 (2022 Jan 19). In: U.S. Department of Health & Human Services, Administration for Children and Families, Administration on Children Youth and Families, Children's Bureau. Accessed: March 2022. Available from: https://www.acf.hhs.gov/cb/data-research/child-maltreatment .
Lindberg D. Child Abuse. Rosen's emergency medicine: concepts and clinical practice 9th ed.2017; Philadelphia, PA: Elsevier, 2225–2236.
Noble J, Hartwig E, Shwayder T. Cutaneous manifestations of physical and sexual child abuse. Indian J Paediatr Dermatol 2020; 21:1–10.
Pierce MC, Kaczor K, Lorenz DJ, et al. Validation of a clinical decision rule to predict abuse in young children based on bruising characteristics. JAMA Netw Open 2021; 4:e215832.
Maiese A, Iannaccone F, Scatena A, et al. Pediatric abusive head trauma: a systematic review. Diagnostics (Basel) 2021; 11:734.
Binenbaum G, Rogers DL, Forbes BJ, et al. Patterns of retinal hemorrhage associated with increased intracranial pressure in children. Pediatrics 2013; 132:e430–e434.
Ramien M, Goldman JL. Pediatric SJS-TEN: Where are we now? F1000Res. 2020 Aug 13;9:F1000 Faculty Rev-982. doi: 10.12688/f1000research.20419.1.
Paulmann M, Mockenhaupt M. Fever in Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric cases: laboratory work-up and antibiotic therapy. Pediatr Infect Dis J 2017; 36:513–515.
Dibek Misirlioglu E, Guvenir H, Bahceci S, et al. Severe cutaneous adverse drug reactions in pediatric patients: a multicenter study. J Allergy Clin Immunol Pract 2017; 5:757–763.
Manvi S, Mahajan VK, Mehta KS, et al. The clinical characteristics, putative drugs, and optimal management of 62 patients with stevens-johnson syndrome and/or toxic epidermal necrolysis: a retrospective observational study. Indian Dermatol Online J 2022; 13:23–31.
2022; Liew YCC, Choo KJL, Oh CC, et al. Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized centerJT J Am Acad Dermatol. 86:811–817.
Abrol A, Gulanikar A, Thakre S, Patel A. Study of ocular manifestations of Stevens-Johnson syndrome/toxic epidermal necrolysis. Indian Dermatol Online J 2020; 11:570–574.